本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ovid Therapeutics Inc.

0.6054
+0.055410.07%
盘后0.62000.0146+2.41%19:59 EDT
成交量:282.50万
成交额:167.28万
市值:4,304.97万
市盈率:-1.77
高:0.6266
开:0.5677
低:0.5600
收:0.5500
数据加载中...
2020/07/13

重要事件披露

8-K - Current report
2020/06/19

重要事件披露

8-K - Current report
2020/06/17

重要事件披露

8-K - Current report
2020/06/05

重要事件披露

8-K - Current report
2020/05/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2020/03/30

重要事件披露

Current report, items 8.01 and 9.01
2020/03/27

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/13

重要事件披露

Current report, items 7.01 and 9.01
2020/03/11

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/11

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/11

重要事件披露

Current report, items 2.02 and 9.01
2020/03/02

重要事件披露

Current report, items 7.01 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals